Correlation Between Quest PharmaTech and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Trevi Therapeutics, you can compare the effects of market volatilities on Quest PharmaTech and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Trevi Therapeutics.
Diversification Opportunities for Quest PharmaTech and Trevi Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and Trevi is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between Quest PharmaTech and Trevi Therapeutics
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Trevi Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 1.48 times less risky than Trevi Therapeutics. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Trevi Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 185.00 in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of 240.50 from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. Trevi Therapeutics
Performance |
| Timeline |
| Quest PharmaTech |
| Trevi Therapeutics |
Quest PharmaTech and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and Trevi Therapeutics
The main advantage of trading using opposite Quest PharmaTech and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |